SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-004146
Filing Date
2013-04-09
Accepted
2013-04-09 16:15:59
Documents
6
Period of Report
2013-05-23
Effectiveness Date
2013-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214301zdef14a.htm DEF 14A 1073118
2 G23452BCI001.GIF g23452bci001.gif GRAPHIC 57381
3 G23452BCI002.GIF g23452bci002.gif GRAPHIC 38437
4 G583995.JPG g583995.jpg GRAPHIC 10770
5 G119365.JPG g119365.jpg GRAPHIC 6148
6 G371368.JPG g371368.jpg GRAPHIC 5201
  Complete submission text file 0001047469-13-004146.txt   1237393
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-28298 | Film No.: 13751273
SIC: 2836 Biological Products, (No Diagnostic Substances)